Abstract

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin

Author(s): Riepl Mike

Issue: Mar/Apr 2022 - Volume 26, Number 2

Page(s): 94-98

Download in electronic PDF format for $75
  • A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Page 1
  • A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Page 2
  • A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Page 3
  • A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Page 4
  • A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Page 5

Abstract

When compounded with synergistic ingredients, many pathogenicidal or anti-inflammatory drugs are particularly effective in resolving dermal or mucosal wounds that have proven refractory to treatment with standardized medications. In a customized preparation, such agents offer therapy that can be easily revised to repair injured tissues, minimize discomfort, and reduce morbidity. In this article, profiles of metronidazole, misoprostol, and phenytoin (drugs with often underappreciated wound-healing effects) are presented, and formulations designed to restore tissue integrity are provided for easy reference.

Related Keywords

  • wound healing
  • skin lesions
  • mucosal lesions
  • metronidazole
  • misoprostol
  • phenytoin
  • formulations
  • tissue integrity
  • topical preparations
  • epithelialization
  • wound odors
  • collagen
  • peptic ulcers
  • diabetes
  • fibroblast proliferation
  • foot ulcers
  • decubitus ulcers
  • venous stasis ulcers
  • pressure ulcers
  • bedsores

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • WOUND CARE
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Author(s): Riepl Mike
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Mar/Apr 2002
Pg. 92-95
Options in Wound Care
Author(s): Kincaid Michele R
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Sep/Oct 2015
Pg. 406
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 282-287
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Author(s): Riepl Mike
Jul/Aug 2004
Pg. 299
Metronidazole 2%, Misoprostol 0.0024% and Phenytoin 5% Topical Gel
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 189-193
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Author(s): Riepl Mike
Jan/Feb 2022
Pg. 18-23
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Author(s): Riepl Mike
Nov/Dec 2004
Pg. 472
Gentamicin Sulfate 0.2%, Misoprostol 0.0024%, and Phenytoin 5% Topical Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 100-103
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Author(s): Riepl Mike
Jul/Aug 2004
Pg. 298
Lidocaine HCl 2%, Misoprostol 0.0024% and Phenytoin 2% Topical Wound Powder
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 278-281
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Author(s): Riepl Mike
May/Jun 2020
Pg. 182-186
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Author(s): Riepl Mike
Jul/Aug 2000
Pg. 301
Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 282-285
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Author(s): Riepl Mike
Jan/Feb 2006
Pg. 74-78
Stability of Phenytoin Sodium Suspensions for the Treatment of Open Wounds
Author(s): Rhodes Richard S, Kuykendall Jim R, Heyneman Catherine A, May Matthew P, Bhushan Alok
Jul/Aug 2007
Pg. 333
Phenytoin Sodium 20-mg/mL Topical Suspension
Author(s): Allen Loyd V Jr